MARC HOROWITZ to Ependymoma
This is a "connection" page, showing publications MARC HOROWITZ has written about Ependymoma.
Connection Strength
0.311
-
Benefit from prolonged dose-intensive chemotherapy for infants with malignant brain tumors is restricted to patients with ependymoma: a report of the Pediatric Oncology Group randomized controlled trial 9233/34. Neuro Oncol. 2014 Mar; 16(3):457-65.
Score: 0.102
-
Feasibility and efficacy of preirradiation chemotherapy for pediatric brain tumors. Neurosurgery. 1988 Apr; 22(4):687-90.
Score: 0.069
-
Development and characterization of human ependymoma xenograft HxBr5. Cancer Res. 1987 Jan 15; 47(2):499-504.
Score: 0.063
-
Prognostic factors in infants and very young children with intracranial ependymomas. Pediatr Neurosurg. 1998 Apr; 28(4):215-22.
Score: 0.034
-
Postoperative chemotherapy and delayed radiation in children less than three years of age with malignant brain tumors. N Engl J Med. 1993 Jun 17; 328(24):1725-31.
Score: 0.025
-
The treatment of malignant brain tumors in infants and very young children: an update of the Pediatric Oncology Group experience. Neuro Oncol. 1999 04; 1(2):152-61.
Score: 0.009
-
A phase II evaluation of thiotepa in pediatric central nervous system malignancies. Cancer. 1993 Jul 01; 72(1):271-5.
Score: 0.006
-
Regional blood flow in ethylnitrosourea-induced brain tumors. Ann Neurol. 1983 Aug; 14(2):189-201.
Score: 0.003